Siamak Daneshmand, MD

Professor of Urology (Clinical Scholar)

Director of Clinical Research

Image of Siamak Daneshmand, MD
Is this your profile? Click to edit

Overview

Dr. Sia Daneshmand earned his medical degree at the University of California, Davis and completed his residency at the University of Southern California (USC) followed by a two-year fellowship in Urologic Oncology at the USC/Norris Comprehensive Cancer Center. He spent almost 6 years at Oregon Health and Science University where he established the Section of Urologic Oncology as a center of excellence for treatment of bladder and testis cancers. He was recruited to USC Institute of Urology in 2010 as Director of Urologic Oncology. He is currently an associate professor of urology with clinical scholar designation and serves as director of clinical research as well as the urologic oncology fellowship director. Dr. Daneshmand’s main interests include bladder cancer, advanced kidney cancer and testicular cancer. He has extensive experience in urinary diversion and reconstruction following surgical removal of the bladder (radical cystectomy) as well as nerve-sparing retroperitoneal lymph node dissection (RPLND) following chemotherapy for advanced testis cancer. He is one of the highest volume surgeons for this disease on the west coast. He has been selected as one of “True Experts” in the Testicular Cancer Resource Center web site. He also has extensive experience in the management of advanced kidney cancers with vena caval tumor thrombus involvement, as well as prostate cancer, retroperitoneal sarcomas and surgeries requiring replacement of the great vessels. He is a member of Alpha Omega Alpha medical honor society, and has been designated one of the “America’s Top Doctors” for several years. He is an active member of the Society of Urologic Oncology, has presented over 150 abstracts at scientific meetings and has authored over 120 peer-reviewed articles, reviews, and chapters. He is a reviewer for numerous urology journals.

Publications

  • Access to high-volume surgeons and the opportunity cost of performing radical prostatectomy by low-volume providersUrol Oncol. 2017 07; 35(7):459. e15-459. e24. . View in PubMed
  • Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)Urol Oncol. 2018 02; 36(2):79. e11-79. e17. . View in PubMed
  • The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinomaUrol Oncol. 2018 01; 36(1):10. e7-10. e14. . View in PubMed
  • Urol Oncol. 2018 Jul; 36(7):339. e1-339. e8. . View in PubMed
  • The safety, tolerability, and efficacy of a neoadjuvant gemcitabine intravesical drug delivery system (TAR-200) in muscle-invasive bladder cancer patients: a phase I trialUrol Oncol. 2022 07; 40(7):344. e1-344. e9. . View in PubMed
  • Association between early postradical cystectomy kidney injury and perioperative outcome in enhanced recovery eraUrol Oncol. 2023 09; 41(9):389. e15-389. e20. . View in PubMed
  • Safety of repeat blue light cystoscopy with hexaminolevulinate (HAL) in the management of bladder cancer: Results from a phase III, comparative, multi-center studyUrol Oncol. 2022 08; 40(8):382. e1-382. e6. . View in PubMed
  • Chronic kidney disease and radical cystectomy for bladder cancer: perioperative and oncologic outcomes in 1,214 patientsUrol Oncol. 2022 08; 40(8):381. e9-381. e16. . View in PubMed
  • Factors influencing ICU admission and associated outcome in patients undergoing radical cystectomy with enhanced recovery pathwayUrol Oncol. 2019 09; 37(9):572. e13-572. e19. . View in PubMed
  • Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registryUrol Oncol. 2018 08; 36(8):361. e1-361. e6. . View in PubMed
  • The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomyUrol Oncol. 2020 01; 38(1):3. e17-3. e27. . View in PubMed
  • Urinary tract infections following radical cystectomy with enhanced recovery protocol: A prospective studyUrol Oncol. 2020 03; 38(3):75. e9-75. e14. . View in PubMed
  • Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancerUrol Oncol. 2020 07; 38(7):639. e1-639. e9. . View in PubMed
  • Restrictive transfusion in radical cystectomy is safeUrol Oncol. 2017 08; 35(8):528. e15-528. e21. . View in PubMed
  • Utilization of retroperitoneal lymph node dissection for testicular cancer in the United States: Results from the National Cancer Database (1998-2011)Urol Oncol. 2016 11; 34(11):487. e7-487. e11. . View in PubMed
  • Radical cystectomy and urinary diversion outcomes in patients with single vsdouble renal unit: A 2:1 matched-pair analysis. Urol Oncol. 2023 04; 41(4):207. e17-207. e22. . View in PubMed
  • Macro and microeconomics of blue light cystoscopy with CYSVIEW® in non-muscle invasive bladder cancerUrol Oncol. 2022 01; 40(1):10. e7-10. e12. . View in PubMed
  • Recurrence patterns in bladder cancer patients with no residual disease (pT0N0) at radical cystectomy: A 20-year experienceUrol Oncol. 2023 02; 41(2):107. e9-107. e14. . View in PubMed
  • Assessing trends in urinary diversion after radical cystectomy for bladder cancer in the United StatesUrol Oncol. 2019 03; 37(3):180. e1-180. e9. . View in PubMed
  • Preoperative chemotherapy in clinically node positive muscle invasive bladder cancer: Radiologic variables can predict responseUrol Oncol. 2021 02; 39(2):133. e1-133. e8. . View in PubMed
  • Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) membersUrol Oncol. 2020 10; 38(10):796. e1-796. e6. . View in PubMed
  • Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma Eur Urol. 2024 Feb; 85(2):114-122. . View in PubMed
  • Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial Nat Med. 2024 Jan 19. . View in PubMed
  • Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer Clin Cancer Res. 2024 Jan 17; 30(2):444-449. . View in PubMed
  • Diagnosis and Treatment of Early-Stage Testicular Cancer: AUA Guideline Amendment 2023 J Urol. 2024 Jan; 211(1):20-25. . View in PubMed
  • Interruptions in bladder cancer care during the COVID-19 public health emergency Urol Oncol. 2023 Dec 11. . View in PubMed
  • Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer J Clin Oncol. 2023 Dec 01; 41(34):5296-5305. . View in PubMed
  • Reply to ARumyantsev et al. J Clin Oncol. 2023 Nov 20; 41(33):5203-5204. . View in PubMed
  • Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial Nat Med. 2023 Nov; 29(11):2825-2834. . View in PubMed
  • Comparative Cost-effectiveness of Contemporary Treatment Strategies for Stage IIA Seminoma J Natl Cancer Inst. 2023 Oct 11. . View in PubMed
  • The effect of cisplatin-based neoadjuvant chemotherapy on the renal function of patients undergoing radical cystectomy Can Urol Assoc J. 2023 Oct; 17(10):301-309. . View in PubMed
  • Metastatic Testicular Cancer Patterns and Predictors: A Contemporary Population-based SEER Analysis Urology. 2023 Oct; 180:182-189. . View in PubMed
  • Survival of Patients with Chronic Kidney Disease Treated with Radical Cystectomy and Risk Factors of Glomerular Filtration Rate Loss Following Radical Cystectomy: Two Systematic Reviews and Meta-analyses of Interplay Between Radical Cystectomy and Renal Function Eur Urol Focus. 2023 Jul 11. . View in PubMed
  • Carboplatin Induction Chemotherapy in Clinically Lymph Node-positive Bladder Cancer Eur Urol Open Sci. 2023 May; 51:39-46. . View in PubMed
  • Perioperative mortality for radical cystectomy in the modern Era: experience from a tertiary referral center Int Braz J Urol. 2023 May-Jun; 49(3):351-358. . View in PubMed
  • Retroperitoneal Lymph Node Dissection Should Be a Standard-of-Care Treatment Option For Stage II Seminoma Eur Urol Open Sci. 2023 Mar; 49:67-68. . View in PubMed
  • Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis Cancers (Basel). 2023 Feb 23; 15(5). . View in PubMed
  • So, what now? Ann Oncol. 2023 12; 34(12):1077-1079.. View in PubMed
  • Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314 Eur Urol Oncol. 2023 10; 6(5):516-524. . View in PubMed
  • Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695) Eur Urol. 2023 09; 84(3):341-347. . View in PubMed
  • Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guérin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naïve High-grade Non-muscle-invasive Bladder Cancer (BRIDGE) Eur Urol Focus. 2023 07; 9(4):561-563. . View in PubMed
  • Association Between Antibiotic Prophylaxis Before Cystectomy or Stent Removal and Infection Complications: A Systematic Review Eur Urol Focus. 2023 07; 9(4):631-636. . View in PubMed
  • Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis Lancet Oncol. 2023 06; 24(6):669-681. . View in PubMed
  • A Urine-based DNA Methylation Marker Test to Detect Upper Tract Urothelial Carcinoma: A Prospective Cohort Study J Urol. 2023 05; 209(5):854-862. . View in PubMed
  • Impact of Maximal Transurethral Resection on Pathological Outcomes at Cystectomy in a Large, Multi-institutional Cohort J Urol. 2023 05; 209(5):882-889. . View in PubMed
  • Reply by Authors J Urol. 2023 05; 209(5):862. . View in PubMed
  • Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification J Urol. 2023 04; 209(4):762-772. . View in PubMed
  • Primary Retroperitoneal Lymph Node Dissection in Stage I and Low-volume Metastatic Germ Cell Tumors Eur Urol Focus. 2023 03; 9(2):248-250. . View in PubMed
  • Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study Eur J Cancer. 2023 03; 182:144-154. . View in PubMed
  • Diagnostic Accuracy of Clinical Lymph Node Staging for Upper Tract Urothelial Cancer Patients: A Multicenter, Retrospective, Observational Study J Urol. 2023 03; 209(3):515-524. . View in PubMed
  • Late Complication of Orthotopic T-Pouch Ileal Neobladder Diversion Urology. 2023 02; 172:e1-e2. . View in PubMed
  • Is a restaging TURBT necessary in high-risk NMIBC if the initial TURBT was performed with blue light? Urol Oncol. 2023 02; 41(2):109.e9-109.e14.. View in PubMed
  • Development of a Pocket Nomogram to Predict Cancer and Disease Specific Survival After Radical Cystectomy For Bladder Cancer: The CRAB Nomogram Clin Genitourin Cancer. 2023 02; 21(1):108-114. . View in PubMed
  • Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy J Clin Oncol. 2023 06 01; 41(16):3009-3018. . View in PubMed
  • Feminizing Adrenocortical Tumor with Multiple Recurrences: A Case Report Case Rep Oncol. 2023 Jan-Dec; 16(1):1033-1040. . View in PubMed
  • Plasma Micro-RNA 371 Expression in Early-Stage Germ Cell Tumors: Are We Ready to Move Toward Biology-Based Decision Making? J Clin Oncol. 2023 05 10; 41(14):2478-2482.. View in PubMed
  • Reply by Authors Urol Pract. 2022 Nov; 9(6):541. . View in PubMed
  • Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer World J Urol. 2022 Nov; 40(11):2707-2715. . View in PubMed
  • An Assessment Tool to Provide Targeted Feedback to Robotic Surgical Trainees: Development and Validation of the End-To-End Assessment of Suturing Expertise (EASE) Urol Pract. 2022 Nov; 9(6):532-539. . View in PubMed
  • Impact of Patient, Surgical, and Perioperative Factors on Discharge Disposition after Radical Cystectomy Cancers (Basel). 2022 Oct 27; 14(21). . View in PubMed
  • Race reporting and disparities regarding clinical trials in bladder cancer: a systematic review Cancer Causes Control. 2022 Aug; 33(8):1071-1081. . View in PubMed
  • Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial Future Oncol. 2022 Jul; 18(21):2599-2614. . View in PubMed
  • Critical analysis of quality of life and cost-effectiveness of enhanced recovery after surgery (ERAS) for patient’s undergoing urologic oncology surgery: a systematic review World J Urol. 2022 Jun; 40(6):1325-1342. . View in PubMed
  • Association between use of ERAS protocols and complications after radical cystectomy World J Urol. 2022 Jun; 40(6):1311-1316. . View in PubMed
  • Pediatric genitourinary tumors: Distribution, demographics, and outcomes Pediatr Investig. 2022 Jun; 6(2):85-92. . View in PubMed
  • Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care Metrics Cancers (Basel). 2022 Mar 31; 14(7). . View in PubMed
  • 5-Aminolevulinic acid-enhanced fluorescence-guided treatment of high-grade glioma using angled endoscopic blue light visualization: technical case series with preliminary follow-up J Neurosurg. 2022 Mar 18; 1-9. . View in PubMed
  • Utility of Blue Light Cystoscopy for Post-bacillus Calmette-Guérin Bladder Cancer Recurrence Detection: Implications for Clinical Trial Recruitment and Study Comparisons J Urol. 2022 Mar; 207(3):534-540. . View in PubMed
  • Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 Cases J Urol. 2022 Feb; 207(2):302-313. . View in PubMed
  • Clinical stage II seminoma: management options World J Urol. 2022 Feb; 40(2):343-348. . View in PubMed
  • Machine Learning to Delineate Surgeon and Clinical Factors That Anticipate Positive Surgical Margins After Robot-Assisted Radical Prostatectomy J Endourol. 2022 09; 36(9):1192-1198. . View in PubMed
  • Risk factors and natural history of parastomal hernia after radical cystectomy and ileal conduit BJU Int. 2022 09; 130(3):381-388. . View in PubMed
  • Long-term renal function in patients with chronic kidney disease following radical cystectomy and orthotopic neobladder BJU Int. 2022 08; 130(2):200-207. . View in PubMed
  • Role of blue-light cystoscopy in detecting invasive bladder tumours: data from a multi-institutional registry BJU Int. 2022 07; 130(1):62-67. . View in PubMed
  • Re: Detection Rate of CIS During TURBT Following Shift From PDD to NBI in a Single University Hospital Urology. 2022 07; 165:e47. . View in PubMed
  • Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma Clin Genitourin Cancer. 2022 02; 20(1):35-42. . View in PubMed
  • Bladder Recurrence Following Diagnostic Ureteroscopy in Patients Undergoing Nephroureterectomy for Upper Tract Urothelial Cancer: Is Ureteral Access Sheath Protective? Urology. 2022 02; 160:142-146.. View in PubMed
  • Reply by Authors J Urol. 2022 02; 207(2):313. . View in PubMed
  • An emerging role for immuno-nutrition in patients undergoing radical cystectomy Nat Rev Urol. 2022 01; 19(1):1-2. . View in PubMed
  • Identifying the Optimal Number of Neoadjuvant Chemotherapy Cycles in Patients with Muscle Invasive Bladder Cancer J Urol. 2022 01; 207(1):70-76. . View in PubMed
  • Intricacies of retroperitoneal lymph node dissection for testis cancer Curr Opin Urol. 2022 Jan 01; 32(1):24-30. . View in PubMed
  • Safety and feasibility of urological procedures in Jehovah’s Witness patients Int J Urol. 2022 Jan; 29(1):83-88. . View in PubMed
  • Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk Cancer Epidemiol Biomarkers Prev. 2022 09 02; 31(9):1769-1779. . View in PubMed
  • Clinical Utility of Rigid Blue Light Cystoscopy: Results from a Post Procedure User Survey in a Prospective Multicenter Registry Urol Pract. 2022 Jan; 9(1):94-100. . View in PubMed
  • Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer World J Urol. 2021 Dec; 39(12):4345-4354. . View in PubMed
  • Enhanced recovery after cystectomy in patients with preoperative narcotic use Can Urol Assoc J. 2021 Oct; 15(10):E563-E568. . View in PubMed
  • Editorial by Bendu KKonneh, John T. Lafin and Aditya Bagrodia on pp.  341-342 of this issue: MicroRNA-371a-3p as a blood-based biomarker in testis cancer. Asian J Urol. 2021 Oct; 8(4):400-406. . View in PubMed
  • Vena Cava Tumor Thrombus Associated With Renal Angiomyolipoma in a Jehovah’s Witness Patient Urology. 2021 Oct; 156:e86-e87. . View in PubMed
  • Reply by Authors Urol Pract. 2021 Sep; 8(5):604. . View in PubMed
  • Impact of Non-guideline-directed Care on Quality of Life in Testicular Cancer Survivors Eur Urol Focus. 2021 Sep; 7(5):1137-1142. . View in PubMed
  • Perioperative outcomes of goal-directed versus conventional fluid therapy in radical cystectomy with enhanced recovery protocol Int Urol Nephrol. 2021 Sep; 53(9):1827-1833. . View in PubMed
  • Development and validation of an objective scoring tool to evaluate surgical dissection: Dissection Assessment for Robotic Technique (DART) Urol Pract. 2021 Sep; 8(5):596-604. . View in PubMed
  • Performance of Narrow Band Imaging (NBI) and Photodynamic Diagnosis (PDD) Fluorescence Imaging Compared to White Light Cystoscopy (WLC) in Detecting Non-Muscle Invasive Bladder Cancer: A Systematic Review and Lesion-Level Diagnostic Meta-Analysis Cancers (Basel). 2021 Aug 30; 13(17). . View in PubMed
  • Role of Ki-67, MRE11, and PD-L1 as Predictive Biomarkers for Recurrence Pattern in Muscle-invasive Bladder Cancer Anticancer Res. 2021 Aug; 41(8):3851-3857. . View in PubMed
  • Stoma complications and quality of life in patients with Indiana pouch versus appendico/neo-appendico-umbilicostomy urinary diversions World J Urol. 2021 May; 39(5):1521-1529. . View in PubMed
  • The Diagnostic Performance of Cxbladder Resolve, Alone and in Combination with Other Cxbladder Tests, in the Identification and Priority Evaluation of Patients at Risk for Urothelial Carcinoma J Urol. 2021 12; 206(6):1380-1389. . View in PubMed
  • Patient Reported Sexual Function Outcomes in Male Patients Following Open Radical Cystoprostatectomy and Urinary Diversion Urology. 2021 11; 157:161-167. . View in PubMed
  • Validation of the COBRA nomogram for the prediction of cancer specific survival in patients treated with radical cystectomy for bladder cancer: An international wide cohort study Eur J Surg Oncol. 2021 10; 47(10):2646-2650. . View in PubMed
  • Evaluation of Bowel Function Following Radical Cystectomy and Urinary Diversion Using Two Validated Questionnaires: What Are the Effects on Quality of Life? Urology. 2021 10; 156:279-284.. View in PubMed
  • Predictors of need for catheterisation and urinary retention after radical cystectomy and orthotopic neobladder in male patients BJU Int. 2021 09; 128(3):304-310. . View in PubMed
  • A Massive Penile Tumor Urology. 2021 08; 154:e5-e6. . View in PubMed
  • ctDNA guiding adjuvant immunotherapy in urothelial carcinoma Nature. 2021 07; 595(7867):432-437. . View in PubMed
  • Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis BJU Int. 2021 07; 128(1):79-87. . View in PubMed
  • Diagnosis and Staging of Bladder Cancer Hematol Oncol Clin North Am. 2021 06; 35(3):531-541. . View in PubMed
  • Enhanced Endoscopy with IMAGE1 S CHROMA Improves Detection of Nonmuscle Invasive Bladder Cancer During Transurethral Resection J Endourol. 2021 05; 35(5):647-651. . View in PubMed
  • Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma BJU Int. 2021 05; 127(5):528-537. . View in PubMed
  • Disparities in male versus female oncologic outcomes following bladder preservation: A population-based cohort study Cancer Med. 2021 05; 10(9):3004-3012. . View in PubMed
  • Genetic Differences Between Bladder and Upper Urinary Tract Carcinoma: Implications for Therapy Eur Urol Oncol. 2021 04; 4(2):170-179. . View in PubMed
  • Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial Lancet Oncol. 2021 04; 22(4):525-537. . View in PubMed
  • Feasibility and Outcomes of Orthotopic Ileal Neobladder Reconstruction Following Pelvic Irradiation Urology. 2021 02; 148:198-202. . View in PubMed
  • Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours Eur Urol Oncol. 2021 02; 4(1):12-19. . View in PubMed
  • Prospective evaluation of blue-light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer BJU Int. 2021 01; 127(1):108-113. . View in PubMed
  • Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors Eur Urol. 2021 01; 79(1):16-19. . View in PubMed
  • Multiparametric cystoscopy: is the future here yet? Transl Androl Urol. 2021 Jan; 10(1):1-6.. View in PubMed
  • Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples Clin Epigenetics. 2021 04 21; 13(1):84. . View in PubMed
  • A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695) Clin Cancer Res. 2021 05 01; 27(9):2435-2441. . View in PubMed
  • Discrepancies in the Recommended Management of Adrenal Incidentalomas by Various Guidelines J Urol. 2021 Jan; 205(1):52-59. . View in PubMed
  • A Novel DNA Methylation Signature as an Independent Prognostic Factor in Muscle-Invasive Bladder Cancer Front Oncol. 2021; 11:614927. . View in PubMed
  • Internal audit of an enhanced recovery after surgery protocol for radical cystectomy World J Urol. 2020 Dec; 38(12):3131-3137. . View in PubMed
  • Optimizing Outcomes in Urological Surgery: Postoperative Care Urol Pract. 2020 Nov; 7(6):521-529. . View in PubMed
  • Perioperative complications and oncological outcomes following radical cystectomy among different racial groups: A long-term, single-center study Can Urol Assoc J. 2020 Oct; 14(10):E493-E498. . View in PubMed
  • Detecting Invisible Bladder Cancers With Blue Light Cystoscopy Urology. 2020 May; 139:e8-e9. . View in PubMed
  • Back to the Future-Moving Forward for Testicular Cancer Survivors JNCI Cancer Spectr. 2020 Apr; 4(2):pkz082. . View in PubMed
  • Hyperphosphatemia Secondary to the Selective Fibroblast Growth Factor Receptor 1-3 Inhibitor Infigratinib (BGJ398) Is Associated with Antitumor Efficacy in Fibroblast Growth Factor Receptor 3-altered Advanced/Metastatic Urothelial Carcinoma Eur Urol. 2020 12; 78(6):916-924. . View in PubMed
  • Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis Eur Urol. 2020 11; 78(5):719-730. . View in PubMed
  • Reply to Gianluca Giannarini, Vincenzo Ficarra, and Claudio Valotto’s Letter to the Editor re: Stephen BWilliams, Marcus G. K. Cumberbatch, Ashish M. Kamat, et al. Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis. Eur Urol. In press. https://doi. org/10. 1016/j. eururo. 2020. 06. 039. Eur Urol. 2020 11; 78(5):e190-e191. . View in PubMed
  • Occult Nodal Metastases in Patients Down-Staged to Nonmuscle Invasive Disease Following Neoadjuvant Chemotherapy Urology. 2020 08; 142:155-160. . View in PubMed
  • Chemoradiation for Management of Locally Recurrent or Residual Bladder Cancer: A Case Series and Review of the Literature Clin Genitourin Cancer. 2020 08; 18(4):e473-e477. . View in PubMed
  • AUTHOR REPLY Urology. 2020 08; 142:154. . View in PubMed
  • Perioperative Outcome of Suprarenal Resection of Vena Cava Without Reconstruction in Urologic Malignancies: A Case Series and Review of the Literature Urology. 2020 08; 142:146-154. . View in PubMed
  • National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013 Eur Urol Oncol. 2020 06; 3(3):343-350. . View in PubMed
  • EDITORIAL COMMENT Urology. 2020 06; 140:120-121. . View in PubMed
  • Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer Eur Urol. 2020 06; 77(6):669-670. . View in PubMed
  • Adult genitourinary sarcoma: A population-based analysis of clinical characteristics and survival Urol Oncol. 2020 05; 38(5):334-343. . View in PubMed
  • Role of primary retroperitoneal lymph node dissection in stage I and low-volume metastatic germ cell tumors Curr Opin Urol. 2020 03; 30(2):251-257. . View in PubMed
  • Editorial: Refining the role of primary retroperitoneal lymph node dissection in the management of early-stage testicular cancer Curr Opin Urol. 2020 03; 30(2):234. . View in PubMed
  • Bladder Cancer: Advances and Innovations Eur Urol Focus. 2020 07 15; 6(4):613-614. . View in PubMed
  • Surgical strategies for postchemotherapy testis cancer Transl Androl Urol. 2020 Jan; 9(Suppl 1):S74-S82. . View in PubMed
  • Zero, Some Chemotherapy Game in Early-Stage Germ Cell Tumors J Clin Oncol. 2020 07 01; 38(19):2214-2215. . View in PubMed
  • Active surveillance for low-risk prostate cancer – in pursuit of a standardized protocol Cent European J Urol. 2020; 73(2):123-126. . View in PubMed
  • Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results Cancer. 2020 06 01; 126(11):2597-2606. . View in PubMed
  • Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence Eur Urol Focus. 2020 07 15; 6(4):639-641. . View in PubMed
  • Quality reporting in postchemotherapy retroperitoneal lymph node dissection Cancer. 2020 11 15; 126(22):4825. . View in PubMed
  • High-grade T1 Urothelial Carcinoma: Where Do We Stand? Curr Urol Rep. 2019 Nov 28; 20(12):79.. View in PubMed
  • Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma Eur J Surg Oncol. 2019 Oct; 45(10):1983-1992. . View in PubMed
  • Factors influencing intraoperative conversion from planned orthotopic to non-orthotopic urinary diversion during radical cystectomy World J Urol. 2019 Sep; 37(9):1851-1855. . View in PubMed
  • Advanced Testis Cancer Eur Urol Focus. 2019 Sep; 5(5):710-712. . View in PubMed
  • Postchemotherapy Resection of Residual Mass in Nonseminomatous Germ Cell Tumor Urol Clin North Am. 2019 Aug; 46(3):389-398. . View in PubMed
  • Retroperitoneal Lymph Node Dissection as an Alternative Treatment Strategy for Low Volume, Clinical Stage II Testicular Seminoma: A Survey of Patients and Providers Urol Pract. 2019 Jul; 6(4):249-255. . View in PubMed
  • Preoperative chemotherapy for prostatic stromal invasive urothelial bladder cancer: comparison of oncological outcomes of male patients with cT4a disease undergoing radical cystectomy with or without preoperative chemotherapy Scand J Urol. 2019 Apr – Jun; 53(2-3):123-128. . View in PubMed
  • Long term oncologic outcome in patients with bladder cancer after radical cystectomy: Impact of carcinoma in situ in the era of neoadjuvant chemotherapy Int Urol Nephrol. 2019 Mar; 51(3):435-441. . View in PubMed
  • Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guérin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial J Urol. 2019 11; 202(5):920-926. . View in PubMed
  • Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer Urology. 2019 11; 133:157-163. . View in PubMed
  • Development and Acceptability Testing of a Patient Decision Aid for Urinary Diversion with Radical Cystectomy J Urol. 2019 11; 202(5):1001-1007. . View in PubMed
  • Surgical approach as a determinant factor of clinical outcome following radical cystectomy: Does Enhanced Recovery After Surgery (ERAS) level the playing field? Urol Oncol. 2019 10; 37(10):765-773.. View in PubMed
  • Socioeconomic and insurance status are independent prognostic indicators of higher disease stage and worse prognosis in bladder cancer Urol Oncol. 2019 10; 37(10):784-790. . View in PubMed
  • Diagnosis and Treatment of Early Stage Testicular Cancer: AUA Guideline J Urol. 2019 08; 202(2):272-281. . View in PubMed
  • Preface Urol Clin North Am. 2019 08; 46(3):xiii. . View in PubMed
  • Evaluation of Cxbladder and Adjudication of Atypical Cytology and Equivocal Cystoscopy Eur Urol. 2019 08; 76(2):238-243. . View in PubMed
  • Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA – update 2018 Nat Rev Urol. 2019 06; 16(6):377-386. . View in PubMed
  • Frailty and preoperative risk assessment before radical cystectomy Curr Opin Urol. 2019 05; 29(3):216-219. . View in PubMed
  • Global, Regional and National Burden of Bladder Cancer, 1990 to 2016: Results from the GBD Study 2016 J Urol. 2019 05; 201(5):893-901. . View in PubMed
  • Testicular Mesothelioma: An Analysis of Epidemiology, Patient Outcomes, and Prognostic Factors Urology. 2019 04; 126:140-144. . View in PubMed
  • Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer Eur Urol Oncol. 2019 03; 2(2):119-125. . View in PubMed
  • Current controversies on the role of lymphadenectomy for bladder cancer Urol Oncol. 2019 03; 37(3):193-200. . View in PubMed
  • Extended hospital stay after radical cystectomy with enhanced recovery protocol Can J Urol. 2019 02; 26(1):9654-9659. . View in PubMed
  • Management of extraretroperitoneal masses in germ cell tumor Curr Opin Urol. 2019 01; 29(1):33-41. . View in PubMed
  • Association between precystectomy epithelial tumor marker response to neoadjuvant chemotherapy and oncological outcomes in urothelial bladder cancer Urol Oncol. 2019 01; 37(1):1-11. . View in PubMed
  • Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma Eur Urol. 2019 01; 75(1):111-128. . View in PubMed
  • Frailty as a predictor of complications after radical cystectomy: A prospective study of various preoperative assessments Urol Oncol. 2019 01; 37(1):40-47. . View in PubMed
  • Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation Urol Oncol. 2019 01; 37(1):48-56. . View in PubMed
  • Patient-reported outcomes of blue-light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study BJU Int. 2019 01; 123(1):35-41. . View in PubMed
  • Growing Teratoma Syndrome of Testicular Origin Urology. 2019 01; 123:20-23. . View in PubMed
  • Molecular Characterization of Neuroendocrine-like Bladder Cancer Clin Cancer Res. 2019 07 01; 25(13):3908-3920. . View in PubMed
  • Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy Spectrum J Clin Oncol. 2019 11 20; 37(33):3090-3098. . View in PubMed
  • Validating the role of ABO blood type in risk of perioperative venous thromboembolism after radical cystectomy World J Urol. 2019 Jan; 37(1):173-179. . View in PubMed
  • Influence of the facility caseload on the subsequent survival of men with localized prostate cancer undergoing radical prostatectomy Cancer. 2019 11 01; 125(21):3853-3863. . View in PubMed
  • Correction to: Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies Curr Urol Rep. 2019 04 04; 20(5):24. . View in PubMed
  • SIU-ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer World J Urol. 2019 Jan; 37(1):61-83. . View in PubMed
  • Correction to: Enhanced Endoscopy in Bladder Cancer Curr Urol Rep. 2019 04 05; 20(5):25. . View in PubMed
  • The impact of patient-related nonmodifiable factors on perioperative outcomes following radical cystectomy with enhanced recovery protocol Ther Adv Urol. 2018 Dec; 10(12):393-401. . View in PubMed
  • Enhanced Endoscopy in Bladder Cancer Curr Urol Rep. 2018 Aug 17; 19(10):84. . View in PubMed
  • Association between race and oncologic outcome following radical prostatectomy for clinically organ-confined prostate cancer: a long-term follow-up study World J Urol. 2018 Aug; 36(8):1233-1239. . View in PubMed
  • Urinary tract infections following radical cystectomy and urinary diversion: a review of 1133 patients World J Urol. 2018 May; 36(5):775-781. . View in PubMed
  • Enhanced Recovery After Surgery Pathways: Role and Outcomes in the Management of Muscle Invasive Bladder Cancer Urol Clin North Am. 2018 May; 45(2):229-239. . View in PubMed
  • Satisfaction With Testicular Prosthesis After Radical Orchiectomy Urology. 2018 Apr; 114:128-132. . View in PubMed
  • Vena Cavoscopy in the Assessment of Intraluminal Vena Caval Tumor Involvement Urology. 2018 Mar; 113:105-109. . View in PubMed
  • The association between intraoperative fluid intake and postoperative complications in patients undergoing radical cystectomy with an enhanced recovery protocol World J Urol. 2018 Mar; 36(3):401-407. . View in PubMed
  • Continent Cutaneous Diversion Urol Clin North Am. 2018 Feb; 45(1):55-65. . View in PubMed
  • Gastrointestinal Complications Following Radical Cystectomy Using Enhanced Recovery Protocol Eur Urol Focus. 2018 12; 4(6):889-894. . View in PubMed
  • Development and validation of surgical training tool: cystectomy assessment and surgical evaluation (CASE) for robot-assisted radical cystectomy for men Surg Endosc. 2018 11; 32(11):4458-4464. . View in PubMed
  • Readmission Following Radical Cystectomy: A Ray of Light in the “Black Box”? Eur Urol Focus. 2018 09; 4(5):718-719.. View in PubMed
  • Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review Eur Urol Oncol. 2018 08; 1(3):223-230. . View in PubMed
  • Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy J Urol. 2018 06; 199(6):1452-1458. . View in PubMed
  • Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study J Urol. 2018 05; 199(5):1158-1165. . View in PubMed
  • The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review Eur Urol. 2018 04; 73(4):543-557. . View in PubMed
  • Clinical Lymphadenopathy in Urothelial Cancer: A Transatlantic Collaboration on Performance of Cross-sectional Imaging and Oncologic Outcomes in Patients Treated with Radical Cystectomy Without Neoadjuvant Chemotherapy Eur Urol Focus. 2018 03; 4(2):245-251. . View in PubMed
  • Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma Adv Urol. 2018; 2018:7978958. . View in PubMed
  • Effectiveness of extended pelvic lymphadenectomy in the survival of prostate cancer: a systematic review and meta-analysis Cent European J Urol. 2018; 71(3):262-269. . View in PubMed
  • Modern Management of Testicular Cancer Cancer Treat Res. 2018; 175:273-308. . View in PubMed
  • Molecular Prognostication in Bladder Cancer Cancer Treat Res. 2018; 175:165-191. . View in PubMed
  • Optimizing Diagnosis of Urothelial Bladder Cancer with Blue Light Cystoscopy via Recognition of False-Positive Lesions Videourology (New Rochelle). 2018; 32(2). . View in PubMed
  • Dose dense MVAC prior to radical cystectomy: a real-world experience World J Urol. 2017 Nov; 35(11):1729-1736. . View in PubMed
  • Feasibility of expert and crowd-sourced review of intraoperative video for quality improvement of intracorporeal urinary diversion during robotic radical cystectomy Can Urol Assoc J. 2017 Oct; 11(10):331-336. . View in PubMed
  • Baseline Glomerular Filtration Rate and Cisplatin- Induced Renal Toxicity in Urothelial Cancer Patients Clin Genitourin Cancer. 2017 Sep 06. . View in PubMed
  • 90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study World J Urol. 2017 Jun; 35(6):907-911. . View in PubMed
  • Transurethral Resection of Bladder Tumors: Improving Quality Through New Techniques and Technologies Curr Urol Rep. 2017 May; 18(5):34. . View in PubMed
  • Oncological Outcomes After Radical Prostatectomy for High-Risk Prostate Cancer Based on New Gleason Grouping System: A Validation Study From University of Southern California With 3,755 Cases Prostate. 2017 May; 77(7):743-748. . View in PubMed
  • Lymph node dissection in bladder cancer: Where do we stand? World J Urol. 2017 Apr; 35(4):527-533.. View in PubMed
  • Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease World J Urol. 2017 Mar; 35(3):327-335. . View in PubMed
  • Association of Distance to Treatment Facility With Survival and Quality Outcomes After Radical Cystectomy: A Multi-Institutional StudyClin Genitourin Cancer. 2017 12; 15(6):689-695. e2. . View in PubMed
  • Tolerance of Orthotopic Ileal Neobladders to Radiotherapy: A Multi-institutional Retrospective Study Clin Genitourin Cancer. 2017 12; 15(6):711-716. . View in PubMed
  • Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity Eur Urol. 2017 11; 72(5):814-820. . View in PubMed
  • Adherence to National Comprehensive Cancer Network® Guidelines for Testicular Cancer J Urol. 2017 03; 197(3 Pt 1):684-689. . View in PubMed
  • Practice Makes Perfect: The Rest of the Story in Testicular Cancer as a Model Curable Neoplasm J Clin Oncol. 2017 11 01; 35(31):3525-3528. . View in PubMed
  • Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival J Surg Oncol. 2016 Nov; 114(6):764-768. . View in PubMed
  • Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline J Urol. 2016 Oct; 196(4):1021-9. . View in PubMed
  • Prediction of Lymph Node Metastasis in Patients with Bladder Cancer Using Whole Transcriptome Gene Expression Signatures J Urol. 2016 Oct; 196(4):1036-41. . View in PubMed
  • Incisional and Parastomal Hernia following Radical Cystectomy and Urinary Diversion: The University of Southern California Experience J Urol. 2016 Sep; 196(3):777-81. . View in PubMed
  • Preoperative Imaging for Clinical Staging Prior to Radical Cystectomy Curr Urol Rep. 2016 Sep; 17(9):62. . View in PubMed
  • Gastrointestinal Complications in Patients Who Undergo Radical Cystectomy with Enhanced Recovery Protocol Curr Urol Rep. 2016 Jul; 17(7):50. . View in PubMed
  • Cost Analysis of the Enhanced Recovery After Surgery Protocol in Patients Undergoing Radical Cystectomy for Bladder Cancer Eur Urol Focus. 2016 Apr; 2(1):92-96. . View in PubMed
  • Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer-Does pT0 Predict Better Survival than pTa/Tis/T1? J Urol. 2016 Apr; 195(4 Pt 1):886-93.. View in PubMed
  • Utility and significance of ureteric frozen section analysis during radical cystectomy BJU Int. 2016 Mar; 117(3):463-8. . View in PubMed
  • Robotic Intracorporeal Orthotopic Neobladder: Urodynamic Outcomes, Urinary Function, and Health-related Quality of Life Eur Urol. 2016 Feb; 69(2):247-53. . View in PubMed
  • Radical cystectomy with super-extended lymphadenectomy: impact of separate vs en bloc lymph node submission on analysis and outcomes BJU Int. 2016 Feb; 117(2):253-9. . View in PubMed
  • Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes Eur Urol. 2016 Feb; 69(2):300-10. . View in PubMed
  • Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy J Urol. 2016 12; 196(6):1627-1633. . View in PubMed
  • Prospective Evaluation of Continence Following Radical Cystectomy and Orthotopic Urinary Diversion Using a Validated Questionnaire J Urol. 2016 12; 196(6):1685-1691. . View in PubMed
  • Assessment of Urologists’ Knowledge of Intraoperative Floppy Iris Syndrome Urology. 2016 11; 97:40-45. . View in PubMed
  • Novel Gene Expression Signature Predictive of Clinical Recurrence After Radical Prostatectomy in Early Stage Prostate Cancer Patients Prostate. 2016 10; 76(14):1239-56. . View in PubMed
  • Editorial Comment J Urol. 2016 06; 195(6):1716. . View in PubMed
  • Predictors of time to biochemical recurrence in a radical prostatectomy cohort within the PSA-era Can Urol Assoc J. 2016 Jan-Feb; 10(1-2):E17-22. . View in PubMed
  • Orthotopic urinary diversion in the elderly World J Urol. 2016 Jan; 34(1):13-8. . View in PubMed
  • Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors J Clin Oncol. 2016 07 20; 34(21):2478-83. . View in PubMed
  • Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activityUrol Oncol. 2016 Jan; 34(1):4. e11-7. . View in PubMed
  • A Multi-Institutional Analysis of Outcomes of Patients with Clinically Node Positive Urothelial Bladder Cancer Treated with Induction Chemotherapy and Radical Cystectomy J Urol. 2016 Jan; 195(1):53-9. . View in PubMed
  • Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma World J Urol. 2016 Jan; 34(1):97-103. . View in PubMed
  • Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma Urol Int. 2016; 97(2):134-41. . View in PubMed
  • Orthotopic urinary diversion Curr Opin Urol. 2015 Nov; 25(6):545-9. . View in PubMed
  • Postoperative Pain Management after Radical Cystectomy: Comparing Traditional versus Enhanced Recovery Protocol Pathway J Urol. 2015 Nov; 194(5):1209-13. . View in PubMed
  • Urinary diversion 2015: controversies and new technologies: Choosing the ‘right’ diversion Curr Opin Urol. 2015 Nov; 25(6):543-4. . View in PubMed
  • Urothelial carcinoma in bladder diverticula: outcomes after radical cystectomy World J Urol. 2015 Oct; 33(10):1397-402. . View in PubMed
  • Development and external validation of nomograms predicting disease-free and cancer-specific survival after radical cystectomy World J Urol. 2015 Oct; 33(10):1419-28. . View in PubMed
  • Role of surgical resection for refractory germ cell tumors Urol Oncol. 2015 Aug; 33(8):370-8. . View in PubMed
  • Role of Extraretroperitoneal Surgery in Patients with Metastatic Germ Cell Tumors Urol Clin North Am. 2015 Aug; 42(3):369-80. . View in PubMed
  • Randomized Trial of Studer Pouch versus T-Pouch Orthotopic Ileal Neobladder in Patients with Bladder Cancer J Urol. 2015 Aug; 194(2):433-9. . View in PubMed
  • Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis J Urol. 2015 Aug; 194(2):304-308. . View in PubMed
  • Retroperitoneal Lymph Node Dissection as First-Line Treatment of Node-Positive Seminoma Clin Genitourin Cancer. 2015 Aug; 13(4):e265-e269. . View in PubMed
  • Ureteroenteric Strictures After Open Radical Cystectomy and Urinary Diversion: The University of Southern California Experience Urology. 2015 Jul; 86(1):87-91. . View in PubMed
  • Is frozen section analysis of ureteral margins at time of radical cystectomy useful? Curr Urol Rep. 2015 Jun; 16(6):38.. View in PubMed
  • Female reproductive organ-sparing radical cystectomy: contemporary indications, techniques and outcomes Curr Opin Urol. 2015 Mar; 25(2):105-10. . View in PubMed
  • Venous thromboembolism following radical cystectomy: significant predictors, comparison of different anticoagulants and timing of events J Urol. 2015 Feb; 193(2):565-9. . View in PubMed
  • Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy J Urol. 2015 Feb; 193(2):436-42. . View in PubMed
  • Multicenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer Eur Urol. 2015 Feb; 67(2):241-9. . View in PubMed
  • Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance J Clin Oncol. 2015 Jan 01; 33(1):51-7. . View in PubMed
  • Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review BMC Cancer. 2014 Dec 16; 14:966. . View in PubMed
  • Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy Urology. 2014 Dec; 84(6):1420-6. . View in PubMed
  • Discovery and validation of novel expression signature for postcystectomy recurrence in high-risk bladder cancer J Natl Cancer Inst. 2014 Nov; 106(11). . View in PubMed
  • Significance of perivesical lymph nodes in radical cystectomy for bladder cancer Urol Oncol. 2014 Nov; 32(8):1158-65. . View in PubMed
  • Validation of Surveillance, Epidemiology, and End Results TNM staging for testicular germ cell tumor Urol Oncol. 2014 Nov; 32(8):1341-6. . View in PubMed
  • Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA Nat Rev Urol. 2014 Oct; 11(10):589-96. . View in PubMed
  • Level III-IV inferior vena caval thrombectomy without cardiopulmonary bypass: long-term experience with intrapericardial control J Urol. 2014 Sep; 192(3):682-8. . View in PubMed
  • Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus Eur Urol. 2014 Sep; 66(3):577-83. . View in PubMed
  • Growing teratoma syndrome: clinical and radiographic characteristics Int J Urol. 2014 Sep; 21(9):905-8. . View in PubMed
  • Precystectomy serum levels of carbohydrate antigen 19-9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder Urol Oncol. 2014 Jul; 32(5):648-56. . View in PubMed
  • Enhanced recovery protocol after radical cystectomy for bladder cancer J Urol. 2014 Jul; 192(1):50-5. . View in PubMed
  • Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review Eur Urol. 2014 Jul; 66(1):120-37. . View in PubMed
  • The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer BJU Int. 2014 Jun; 113(6):887-93. . View in PubMed
  • Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy BJU Int. 2014 Apr; 113(4):554-60. . View in PubMed
  • Reprogramming of the human intestinal epigenome by surgical tissue transposition Genome Res. 2014 Apr; 24(4):545-53. . View in PubMed
  • Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder Urol Oncol. 2014 Apr; 32(3):230-42. . View in PubMed
  • A panel of three markers hyper- and hypomethylated in urine sediments accurately predicts bladder cancer recurrence Clin Cancer Res. 2014 Apr 01; 20(7):1978-89. . View in PubMed
  • Enhanced recovery pathway following radical cystectomy Curr Opin Urol. 2014 Mar; 24(2):135-9. . View in PubMed
  • Mesenteric lymphadenopathy in testicular germ cell tumor Urology. 2014 Mar; 83(3):e7-8. . View in PubMed
  • Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy Urol Oncol. 2014 Feb; 32(2):110-6. . View in PubMed
  • Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era Urol Oncol. 2014 Feb; 32(2):85-91. . View in PubMed
  • Urol Oncol. 2014 Feb; 32(2):117-27. . View in PubMed
  • Urinary functional outcomes in female neobladder patients World J Urol. 2014 Feb; 32(1):221-8. . View in PubMed
  • Androgen deprivation therapy for prostate cancer: long-term safety and patient outcomes Patient Relat Outcome Meas. 2014; 5:63-70. . View in PubMed
  • Refining patient selection for neoadjuvant chemotherapy before radical cystectomy J Urol. 2014 Jan; 191(1):40-7. . View in PubMed
  • Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patientsUrol Oncol. 2014 Jan; 32(1):52. e1-9. . View in PubMed
  • Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes BJU Int. 2014 Jan; 113(1):11-23. . View in PubMed
  • Outcome in patients with exclusive carcinoma in situ (CIS) after radical cystectomy BJU Int. 2014 Jan; 113(1):65-9. . View in PubMed
  • Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: results from a prospective lymph node mapping studyUrol Oncol. 2014 Jan; 32(1):24. e13-9. . View in PubMed
  • Radical cystectomy and orthotopic urinary diversion in male patients with pT4a urothelial bladder carcinoma: oncological outcomes Int J Urol. 2013 Dec; 20(12):1229-33. . View in PubMed
  • Editorial comment Urology. 2013 Dec; 82(6):1346. . View in PubMed
  • Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens J Urol. 2013 Nov; 190(5):1704-9. . View in PubMed
  • Neoadjuvant chemotherapy with gemcitabine/cisplatin vsmethotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California. Urol Oncol. 2013 Nov; 31(8):1737-43. . View in PubMed
  • Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis Eur Urol. 2013 Nov; 64(5):837-45. . View in PubMed
  • Outcomes after radical prostatectomy for patients with clinical stages T1-T2 prostate cancer with pathologically positive lymph nodes in the prostate-specific antigen era Urol Oncol. 2013 Nov; 31(8):1441-7. . View in PubMed
  • Null association between histology of first and second primary malignancies in men with bilateral testicular germ cell tumors Am J Epidemiol. 2013 Oct 15; 178(8):1240-5. . View in PubMed
  • Active surveillance is the preferred approach to clinical stage I testicular cancer J Clin Oncol. 2013 Oct 01; 31(28):3490-3. . View in PubMed
  • Editorial comment J Urol. 2013 Sep; 190(3):927. . View in PubMed
  • Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades BJU Int. 2013 Jul; 112(2):E51-8. . View in PubMed
  • Minimally invasive postchemotherapy retroperitoneal lymph node dissection: caution and prudence Eur Urol. 2013 Jun; 63(6):1018-9; discussion 1020. . View in PubMed
  • Conversion from incontinent conduit to continent cutaneous reservoir after renal transplant Urology. 2013 May; 81(5):1086-9. . View in PubMed
  • Urinary functional outcome following radical cystoprostatectomy and ileal neobladder reconstruction in male patients J Urol. 2013 May; 189(5):1782-8. . View in PubMed
  • Determining the role of cystectomy for high-grade T1 urothelial carcinoma Urol Clin North Am. 2013 May; 40(2):233-47. . View in PubMed
  • Androgen deprivation therapy: evidence-based management of side effects BJU Int. 2013 Apr; 111(4):543-8. . View in PubMed
  • Editorial comment J Urol. 2013 Apr; 189(4):1318-9. . View in PubMed
  • Principal component analysis based pre-cystectomy model to predict pathological stage in patients with clinical organ-confined bladder cancer BJU Int. 2013 Apr; 111(4 Pt B):E167-72. . View in PubMed
  • Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy BJU Int. 2013 Mar; 111(3 Pt B):E37-42. . View in PubMed
  • Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy Eur Urol. 2013 Feb; 63(2):371-8. . View in PubMed
  • A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer BJU Int. 2013 Feb; 111(2):240-8. . View in PubMed
  • Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy BJU Int. 2013 Feb; 111(2):249-55. . View in PubMed
  • Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy BJU Int. 2013 Jan; 111(1):74-84. . View in PubMed
  • Use of nonabsorbable staples for urinary diversion: a step in the wrong direction Urol Int. 2013; 90(2):125-9. . View in PubMed
  • Reproductive organ involvement in female patients undergoing radical cystectomy for urothelial bladder cancer J Urol. 2012 Dec; 188(6):2134-8. . View in PubMed
  • Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study Urology. 2012 Dec; 80(6):1313-8. . View in PubMed
  • Radical cystectomy with orthotopic neobladder reconstruction following prior radical prostatectomy World J Urol. 2012 Dec; 30(6):741-5. . View in PubMed
  • Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? World J Urol. 2012 Dec; 30(6):807-14.. View in PubMed
  • Robotic intracorporeal orthotopic ileal neobladder: replicating open surgical principles Eur Urol. 2012 Nov; 62(5):891-901. . View in PubMed
  • Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience BJU Int. 2012 Nov; 110(9):1324. . View in PubMed
  • Contemporary management of postchemotherapy testis cancer Eur Urol. 2012 Nov; 62(5):867-76. . View in PubMed
  • Midline extraperitoneal approach for retroperitoneal lymph node dissection for testicular germ cell tumor Urology. 2012 Oct; 80(4):941-5. . View in PubMed
  • Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy Eur Urol. 2012 Oct; 62(4):671-6. . View in PubMed
  • Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery Eur Urol. 2012 Oct; 62(4):677-84. . View in PubMed
  • A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer Eur Urol. 2012 Sep; 62(3):523-33. . View in PubMed
  • Editorial comment Urology. 2012 Sep; 80(3):639; author reply 639-40. . View in PubMed
  • Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection Ann Surg Oncol. 2012 Jul; 19(7):2388-93. . View in PubMed
  • The value of extended transurethral resection of bladder tumour (TURBT) in the treatment of bladder cancer BJU Int. 2012 Jul; 110(2 Pt 2):E80. . View in PubMed
  • Long-term outcomes of open radical retropubic prostatectomy for clinically localized prostate cancer in the prostate-specific antigen era Urology. 2012 Mar; 79(3):626-31. . View in PubMed
  • Factors influencing post-recurrence survival in bladder cancer following radical cystectomy BJU Int. 2012 Mar; 109(6):846-54. . View in PubMed
  • Renal cell carcinoma with inferior vena cava tumor thrombus and metastatic caval wall invasion Urology. 2012 Feb; 79(2):e6-8. . View in PubMed
  • Editorial comment Urology. 2012 Feb; 79(2):481; author reply 481-2. . View in PubMed
  • Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment Eur Urol. 2012 Feb; 61(2):237-42. . View in PubMed
  • Colocalycostomy for repair of ureterojejunal fistula Urology. 2012 Feb; 79(2):e12-4. . View in PubMed
  • Cryptorchidism and testicular germ cell tumors: comprehensive meta-analysis reveals that association between these conditions diminished over time and is modified by clinical characteristics Front Endocrinol (Lausanne). 2012; 3:182. . View in PubMed
  • Chemoresponsive liver hemangioma in a patient with a metastatic germ cell tumor J Clin Oncol. 2011 Dec 10; 29(35):e842-4. . View in PubMed
  • Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study Eur Urol. 2011 Nov; 60(5):946-52. . View in PubMed
  • The management of subcentimeter residual mass in NSGCT: pcRPLND vsobservation. Urol Oncol. 2011 Nov-Dec; 29(6):842-7. . View in PubMed
  • Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study J Urol. 2011 Oct; 186(4):1261-8. . View in PubMed
  • Management of residual mass in nonseminomatous germ cell tumors following chemotherapy Ther Adv Urol. 2011 Aug; 3(4):163-71. . View in PubMed
  • Androgen-producing testicular germ cell tumors J Clin Oncol. 2011 Jul 20; 29(21):e634-5. . View in PubMed
  • Improving selection of appropriate urinary diversion following radical cystectomy for bladder cancer Expert Rev Anticancer Ther. 2011 Jun; 11(6):941-8. . View in PubMed
  • Evaluation and Preservation of Fertility in Patients with Testicular Cancer J Adolesc Young Adult Oncol. 2011 Mar; 1(1):25-9. . View in PubMed
  • Distinctive morphology of renal cell carcinomas in tuberous sclerosis Int J Surg Pathol. 2010 Oct; 18(5):409-18. . View in PubMed
  • Editorial comment Urology. 2010 Oct; 76(4):1001. . View in PubMed
  • Factors influencing the choice of urinary diversion in patients undergoing radical cystectomy BJU Int. 2010 Sep; 106(5):654-7. . View in PubMed
  • Management of disseminated nonseminomatous germ cell tumors with risk-based chemotherapy followed by response-guided postchemotherapy surgery J Clin Oncol. 2010 Feb 01; 28(4):537-42. . View in PubMed
  • Resection of the inferior vena cava without reconstruction for urologic malignancies Urology. 2009 Dec; 74(6):1257-62. . View in PubMed
  • Open partial nephrectomy for pediatric renovascular hypertension ScientificWorldJournal. 2009 Apr 28; 9:287-90. . View in PubMed
  • Re: Appendiceal substitution following right proximal ureter injury Int Braz J Urol. 2009 Jan-Feb; 35(1):90-1. . View in PubMed
  • Venous resection in urological surgery J Urol. 2008 Dec; 180(6):2338-42; discussion 2342. . View in PubMed
  • Words of wisdomRe: use of androgen deprivation therapy for metastatic prostate cancer in older men. Eur Urol. 2008 Nov; 54(5):1201-2. . View in PubMed
  • Application of the Yang-Monti channel in adult continent cutaneous urinary diversion Urology. 2008 Oct; 72(4):828-31. . View in PubMed
  • Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival Hum Pathol. 2007 Oct; 38(10):1547-52. . View in PubMed
  • Re: Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapyS. E. Eggener, K. A. Roehl, O. Yossepowitch and W. J. Catalona, J Urol 2006; 176: 1399-1403. J Urol. 2007 Jun; 177(6):2396; author reply 2396-7. . View in PubMed
  • Bilateral segmental testicular infarction ScientificWorldJournal. 2007 Feb 19; 7:779-83. . View in PubMed
  • Management of difficult germ-cell tumors Oncology (Williston Park). 2006 Nov; 20(12):1565-701575; discussion 1575-6. . View in PubMed
  • Evolving treatment paradigms for locally advanced and metastatic prostate cancer Expert Rev Anticancer Ther. 2006 Nov; 6(11):1639-51. . View in PubMed
  • Prognostic significance of neuroendocrine expression in lymph node-positive prostate cancer Urology. 2006 Jun; 67(6):1247-52. . View in PubMed
  • A critical analysis of perioperative mortality from radical cystectomy J Urol. 2006 Mar; 175(3 Pt 1):886-9; discussion 889-90. . View in PubMed
  • Intraoperative renal cell carcinoma tumor embolization to the right atrium: incidental diagnosis by transesophageal echocardiography Anesth Analg. 2006 Feb; 102(2):378-9. . View in PubMed
  • Adrenal myelolipoma: diagnosis and management Urol J. 2006; 3(2):71-4. . View in PubMed
  • Radical cystectomy for primary neuroendocrine tumors of the bladder: the university of southern california experience J Urol. 2005 Jul; 174(1):93-6. . View in PubMed
  • Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy J Urol. 2005 Jul; 174(1):103-6. . View in PubMed
  • Current clinical trials in renal cell carcinoma Urol Oncol. 2005 Jul-Aug; 23(4):289-92. . View in PubMed
  • EphB4 expression and biological significance in prostate cancer Cancer Res. 2005 Jun 01; 65(11):4623-32. . View in PubMed
  • Ethnic differences in neuroendocrine cell expression in normal human prostatic tissue Urology. 2005 May; 65(5):1008-12. . View in PubMed
  • The importance of an extended lymphadenectomy in the management of high-grade invasive bladder cancer Expert Rev Anticancer Ther. 2004 Dec; 4(6):1007-16. . View in PubMed
  • Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results J Urol. 2004 Dec; 172(6 Pt 1):2252-5. . View in PubMed
  • Renal angiomyolipoma with liposarcomatous transformation: a case report and review of the literature Urol Oncol. 2004 Sep-Oct; 22(5):425-7. . View in PubMed
  • Angiomyolipoma of the kidney: expanding disease spectrum demonstrated by 3 cases Appl Immunohistochem Mol Morphol. 2004 Sep; 12(3):277-83. . View in PubMed
  • New molecular markers for bladder cancer detection Curr Opin Urol. 2004 Sep; 14(5):259-64. . View in PubMed
  • Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder J Urol. 2004 Jul; 172(1):81-4. . View in PubMed
  • Adenomatous polyp of the verumontanum causing bladder outlet obstruction ScientificWorldJournal. 2004 Jun 07; 4 Suppl 1:89-91. . View in PubMed
  • Primary renal carcinoid tumor ScientificWorldJournal. 2004 Jun 03; 4:378-80. . View in PubMed
  • Sonography of spermatic cord leiomyoma: case report and review of the literature J Ultrasound Med. 2004 Apr; 23(4):569-71. . View in PubMed
  • Continent right colon reservoir using a cutaneous appendicostomy Urology. 2004 Mar; 63(3):577-80; discussion 580-1. . View in PubMed
  • Microscopic and gross extravesical extension in pathological staging of bladder cancer J Urol. 2004 Feb; 171(2 Pt 1):640-5. . View in PubMed
  • Benign retroperitoneal schwannoma: a case series and review of the literature Urology. 2003 Dec; 62(6):993-7. . View in PubMed
  • Natural history of surgically treated bladder carcinoma with extravesical tumor extension Cancer. 2003 Sep 01; 98(5):955-61. . View in PubMed
  • Colourachal fistula in an adult presenting with feculent umbilical drainage J Urol. 2003 Jul; 170(1):184. . View in PubMed
  • Molecular prognostication in bladder cancer–a current perspective Eur J Cancer. 2003 Jul; 39(11):1501-10. . View in PubMed
  • Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience Cancer. 2003 Jul 01; 98(1):55-60. . View in PubMed
  • Sarcomatoid renal cell carcinoma with massive osteosarcomatous differentiation: an unusual image in clinical urology Urology. 2003 May; 61(5):1031-2. . View in PubMed
  • Puboprostatic sling repair for treatment of urethral incompetence in adult neurogenic incontinence J Urol. 2003 Jan; 169(1):199-202. . View in PubMed
  • Endoscopic management of renal hemangioma J Urol. 2002 Feb; 167(2 Pt 1):488-9. . View in PubMed
  • Review of techniques to remove a Foley catheter when the balloon does not deflate Urology. 2002 Jan; 59(1):127-9. . View in PubMed
  • Infertile women of advanced reproductive ageVariability of day 3 FSH and E2 levels. J Reprod Med. 1998 Dec; 43(12):1023-6. . View in PubMed